Speakers

This is our speakers

Prof. Ping-Yen Liu, M.S., Ph.D., FECS, FACC

Director, Clinical Medicine Research Center

  • Director:

Director, Clinical Medicine Research Center, National Cheng Kung University Hospital, Tainan, Taiwan

Director, Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan


  • Professor of Medicine:

Institute of Clinical Medicine and Division of Cardiology, Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan


  • Education and Important Experience:

1987-1994    M.D., Kaohsiung Medical University, Kaohsiung, Taiwan

2001-2005 Ph.D., Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan

2006-2008 Postdoctoral Fellowship. Vascular Medicine Research Labs, (James K. Liao) Harvard Medical School, Division of Cardiology, Brigham and Women’s Hospital, MA, USA

2014-2015 Visiting scholar in Preclinical Image Lab of Notre Dame University, IN, USA (Prof. Matthew Leevy)

2014-2015 Visiting scholar in Ronglih Liao’s Cardiomyopathy Research Lab, Brigham and Women’s Hospital, MA, USA

2014-2015 Visiting scholar in Onco-cardiology team in Memorial Sloan-Kettering Cancer Center of New York, USA (Richard Steingart)


  • Position:

2001-2004

Instructor in Medicine, National Cheng-Kung University

2006-2008

Postdoctoral Research Fellowship in Brigham & Women’s Hospital, Harvard Medical School (Mentor & PI: James K. Liao)

2004-2010

Assistant Professor in Medicine, National Cheng-Kung University

2010-2012

Associate Professor of Internal Medicine, National Cheng-Kung University

2013-2015

Associate Professor of Institute of Clinical Medical, College of Medicine, National Cheng-Kung University

2015-Present

Professor of Institute of Clinical Medical, College of Medicine, National Cheng-Kung University


  • Experiences:

2021-Present

Secretary General of Taiwan Society of Lipids & Atherosclerosis

2020

Convener of Cardiology in Ministry of Science and Technology

2019-Present

Director, Clinical Medicine Research Center, National Cheng Kung University Hospital

2019-Present

Director, Institute of Clinical Medicine, National Cheng Kung University

2018-Present

Vice Secretary of International Affairs Committee in Taiwan Society of Cardiology

2018-Present

Vice Coordinator of Research Committee in Internal Medicine, College of Medicine, National Cheng Kung University

2016-Present

Committee Members of Medical Education in Taiwan Society of Cardiology

2015-Present

Executive Director of Taiwan Society of Lipids & Atherosclerosis

2010-Present

Executive Editor of Acta Cardiologica Sinica (Official Journal of Taiwan Society of Cardiology) 

2010-2012

Committee Members of Research Committee in Taiwan Society of Cardiology 

2012-2016

Vice Secretary of Taiwan Society of Cardiology

2012-2016

Chairman of Research Committee in Internal Medicine, College of Medicine, National Cheng Kung University

2012-2016

Vice Secretary of International Affairs and Cross - Strait Exchange Committee in Taiwan Society of Cardiology

2013-2019

Member of IRB in National Cheng Kung University Hospital

2016-2018

Vice Chairman of Hypertension Committee in Taiwan Society of Cardiology

2016-2018

Consultant of Research Committee in Internal Medicine, College of Medicine, National Cheng Kung University

2016-2019

Director of Cardiology, Internal Medicine, National Cheng Kung University Hospital


  • Specialties:
  1. Cardiac Catheterization
  2. Echocardiography
  3. Lipids and Atherosclerosis Research
  4. Gene and AI Research


  • Publications (Selected in 5 years):

Paper :

  1. Liu PY, Choi EK, Kim TS, Kuo JY, Lee JM, On YK, Park SW, Park HW, Shin DG, Wang L, Yen HW, Lee MH; XaMINA Investigators: XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia. Advances in Therapy 2022/05;doi: 10.1007/s12325-022-02102-8
  2. Lai CH, Li KW, Hu FW, Su PF, Hsu IL, Huang MH, Huang YT, Liu PY, Shen MR: Integration of an Intensive Care Unit Visualization Dashboard (i-Dashboard) as a Platform to Facilitate Multidisciplinary Rounds: Cluster-Randomized Controlled Trial. Journal of Medical Internet Research 2022/05;24(5):e35981
  3. Lee WC, Wu PJ, Fang CY, Fang HY, Wu CJ, Liu PY*: The comparison of efficacy and safety between transradial and transfemoral approach for chronic total occlusions intervention: a meta-analysis. Scientific Reports 2022/05;12(1):7591
  4. Chou CC, Chien LY, Lin MF, Wang CJ, Liu PY*: Effects of Aerobic Walking on Memory, Subjective Cognitive Complaints, and Brain-Derived Neurotrophic Factor Among Older Hypertensive Women. Biological Research For Nursing 2022/05;10998004221098974
  5. Huang TC, Lee PT, Huang MS, Chiu PH, Su PF, Liu PY*: The Beneficial Effects of Beta Blockers on the Long-Term Prognosis of Patients With Premature Atrial Complexes. Frontiers in Cardiovascular Medicine 2022/02;9:806743. doi: 10.3389
  6. Lee PT, Huang TC, Huang MH, Hsu LW, Su PF, Liu YW, Hung MH, Liu PY*: The Burden of Ventricular Premature Complex Is Associated With Cardiovascular Mortality. Frontiers in Cardiovascular Medicine 2022/02;8:797976
  7. Kuo FY, Lee CH, Lan WR, Su CH, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Tsukiyama S, Yang WC, Cheng LC, Huang CL, Yin WH, Liu PY*: Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. Journal of the Formosan Medical Association 2022/01;S0929-6646(22)00033-X
  8. Lu LS, Wu YW, Chang JT, Chang WT, Chao TH, Chen HH, Chen YJ, Cheng KH, Hsu WL, Hung CL, Kuo SH, Liang JA, Lin HJ, Liu PY, Liu WS, Liu YW, Shueng PW, Wang CY, Hou CJ, Chiou JF: Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC). Acta Cardiologica Sinica 2022/01;38(1):1-12
  9. Hsuan CF, Lin FJ, Lee TL, Yang KC, Tseng WK, Wu YW, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators: The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease. Scientific Reports 2022/01;12(1):804
  10. Chen PW, Lee CH, Liu PY*: Sex Difference in Bleeding Risk With P2Y12 Inhibitor Agents After Percutaneous Coronary Intervention. JAMA Cardiology 2022/01 doi: 10.1001
  11. Yu CJ, Damaiyanti DW, Yan SJ, Wu CH, Tang MJ, Shieh DB, Liu PP, Liu PY*: The Pathophysiologic Role of Gelsolin in Chronic Kidney Disease: Focus on Podocytes. International Journal of Molecular Sciences 2021/12;22(24):13281
  12. Lee WC, Lee PW, Wu PJ, Fang YN, Chen HC, Lin YS, Fang HY, Chang SH, Liu PY*, Chen MC: The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients. Thrombosis Journal 2021/12;19(1):98
  13. Chang WT, Lin YW, Chen ZC, Liu PY*: The S Protein of SARS-CoV-2 Injures Cardiomyocytes Indirectly through the Release of Cytokines Instead of Direct Action. Acta Cardiologica Sinica 2021/11;37(6):643-647
  14. Lee PT, Liao IC, Lee CH, Hsu LW, Liu PY*: Expression of Vascular Cell Adhesion Molecule-1 in Peripheral Artery Disease is Enriched in Patients with Advanced Kidney Disease. Acta Cardiologica Sinica 2021/11;37(6):591-599
  15. Chou CC, Chien LY, Liaw JJ, Wang CJ, Liu PY*: Association between cognitive function and self-reported antihypertensive medication adherence among middle-aged and older hypertensive women. Journal of Clinical Nursing 2021/10;doi: 10.1111/jocn.16106
  16. Lee WC, Wu PJ, Chen HC, Fang HY, Liu PY, Chen MC: Efficacy and Safety of Ablation for Symptomatic Atrial Fibrillation in Elderly Patients: A Meta-Analysis. Frontiers in Cardiovascular Medicine 2021/09;8:734204
  17. Liu YW, Huang MS, Hsu LW, Chang HY, Lee CH, Lee CY, Chen DP, Li YH, Chao TH, Su PF, Shen MR, Liu PY*: Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents. iScience 2021/09;24(9):103082
  18. Chen TW, Huang TC, Huang CW, Liu PY: Refractory Coronary Stent Thrombosis in a Patient with Chronic Immune Thrombocytopenia on Eltrombopag. Acta Cardiologica Sinica 2021/09;37(5):542-545
  19. Masbuchin AN, Rohman MS, Liu PY*: Role of Glycosylation in Vascular Calcification. International Journal of Molecular Sciences 2021/09;22(18):9829
  20. Chen PW, Tsai ZY, Chao TH, Li YH, Hou CJ, Liu PY*: Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiologica Sinica 2021/07;37(4):355-364
  21. Lan WR, Lin SI, Liao FC, Chang HY, Tsai CT, Wu YJ, Liu PY, Chen CH, Lee YH: Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction. American Journal of Cardiology 2021/07;150:77-81. doi: 10.1016
  22. Chen IC, Chang WT, Hsu PC, Yeh YL, Zheng S, Huang YC, Lin CH, Tsai LM, Lin LJ, Liu PY, Liu YW: Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study. Medicine (Baltimore) 2021/06;100(23):e26272.
  23. Huang TC, Lee PT, Huang MS, Su PF, Liu PY*: Higher premature atrial complex burden from the Holter examination predicts poor cardiovascular outcome. Scientific Reports 2021/06;11(1):12198. doi: 10.1038
  24. Sitjar J, Liao JD, Lee H, Tsai HP, Wang JR, Liu PY*: Challenges of SERS technology as a non-nucleic acid or -antigen detection method for SARS-CoV-2 virus and its variants. Biosensors and Bioelectronics 2021/06;181:113153. doi: 10.1016
  25. Liu PY, Su CH, Kuo FY, Lee WL, Wang YC, Lin WS, Chu PH, Lu TM, Lo PH, Lee CH, Lan WR, Huang CL, Tsukiyama S, Yang WC, Cheng LC, Rafael V, Nikolajsen C, Yin WH: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy. Cardiovascular Intervention and Therapeutics 2021/04;doi: 10.1007/s12928-021-00771-w
  26. Chang HY, Lee CH, Su PL, Li SS, Chen MY, Chen YP, Hsu YT, Tsai WC, Liu PY, Chen TY, Liu YW: Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy. Scientific Reports 2021/03;11(1):7100. doi: 10.1038
  27. Chen YT, Wang HH, Liu PY*: Pentraxin 3: A Biomarker Link between Inflammation and Cardiovascular Risk among Obese Children. Acta Cardiologica Sinica 2021/03;37(2):184-185
  28. Liao CT, Hsieh TH, Shih CY, Liu PY, Wang JD: Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan. Scientific Reports 2021/03;11(1):5608
  29. Shao PH, Liu PY, Chen PW: Enoxaparin-Induced Massive Abdominal Wall Hematoma in a Case Pretreated with Multiple Anti-Thrombotic Agents. Acta Cardiologica Sinica 2021/01;37(1):104-107
  30. Chung WP, Yang HL, Hsu YT, Hung CH, Liu PY, Liu YW, Chan SH, Tsai KL: Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: a randomized controlled trial. Annals of Physical and Rehabilitation Medicine 2021/01;101485. doi: 10.1016
  31. Fang YH, Wang Saprina P. H., Chang HY, Yang PJ, Liu PY, Liu YW: Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease. International Journal of Molecular Sciences 2020/12;22(1):E102
  32. Yang CS, Chiu SC, Liu PY, Wu SN, Lai MC, Huang CW: Gastrodin alleviates seizure severity and neuronal excitotoxicities in the rat lithium-pilocarpine model of temporal lobe epilepsy via enhancing GABAergic transmission. Journal of Ethnopharmacology 2020/12;113751. doi: 10.1016
  33. Chang WT, Liu PY, Wu SN: High Capability of Pentagalloylglucose (PGG) in Inhibiting Multiple Types of Membrane Ionic Currents. International Journal of Molecular Sciences 2020/12;21(24):E9369.
  34. Chong JT, Liu PY, Huang MS, Lu WD: Comparison of Minimally Invasive Thrombectomy with Percutaneous Balloon Angioplasty for Organized Thrombi in Hemodialysis Access. Acta Cardiologica Sinica 2020/11;36(6):603-610
  35. Fang YH, Wang SPH, Chang HY, Yang PJ, Liu PY, Liu YW: Immunogenicity in Stem Cell Therapy for Cardiac Regeneration. Acta Cardiologica Sinica 2020/11;36(6):588-594.
  36. Chang WT, Lin YW, Ho CH, Chen ZC, Liu PY, Shih JY: Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients. Archives of Toxicology 2020/11;doi: 10.1007/s00204-020-02951-8.
  37. Docherty KF, Jhund PS, Bengtsson O, DeMets DL, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Sabatine MS, Sjöstrand M, Solomon SD, McMurray JJV; DAPA-HF Investigators and Committees: Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy. Diabetes Care 2020/11;43(11):2878-2881
  38. Chang WT, Liu PY, Wu SN: Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K + Current and Intermediate-Conductance Ca 2+-Activated K + Channel in Jurkat T-Lymphocytes. Molecules 2020/10;25(19):E4525.
  39. Huang MS, Wang CS, Chiang JH, Liu PY, Tsai WC: Automated Recognition of Regional Wall Motion Abnormalities Through Deep Neural Network Interpretation of Transthoracic Echocardiography. Circulation 2020/10;142(16):1510-1520.
  40. Hsu LW, Chen PW, Chang WT, Lee WH, Liu PY*: The Role of ROCK in Platelet-Monocyte Collaborative Induction of Thromboinflammation during Acute Coronary Syndrome. Thrombosis and Haemostasis 2020/10;120(10):1417-1431
  41. Liu PY, Tsai YS, Chen PL, Tsai HP, Hsu LW, Wang CS, Lee NY, Huang MS, Wu YC, Ko WC, Yang YC, Chiang JH, Shen MR: Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study. Journal of Medical Internet Research 2020/10;22(10):e19878.
  42. Chang WT, Ragazzi E, Liu PY, Wu SN: Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target. European Journal of Pharmacology 2020/09;882:173237. doi: 10.1016
  43. Chang WT, Hughes MW, Liu PY*: The impact of COVID-19 on the research and educational environment in Taiwan -forewarned is forearmed. Journal of the Formosan Medical Association 2020/08;S0929-6646(20)30358-2. doi: 10.1016
  44. Chang WT, Liu PY, Gao ZH, Lee SW, Lee WK, Wu SN: Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of I K(M) or I K(DR) and in the Stimulation of I MEP. Frontiers in Pharmacology 2020/07;11:1091 doi: 10.3389
  45. Ko CY, Weng HK, Liu PY, Chen PW: Heterotopic ossification with femoral vein compression mimicking deep vein thrombosis. Journal of Vascular Surgery Cases and Innovative Techniques 2020/07;6(3):479-482
  46. Hughes MW, Liu PY*: An American's perspective living through COVID-19 in Taiwan. Journal of the Formosan Medical Association 2020/07;S0929-6646(20)30322-3.
  47. Chiang CE, Ueng KC, Chao TH, Lin TH, Wu YJ, Wang KL, Sung SH, Yeh HI, Li YH, Liu PY, Chang KC, Shyu KG, Huang JL, Tsai CD, Hung HF, Liu ME, Chao TF, Cheng SM, Cheng HM, Chu PH, Yin WH, Wu YW, Chen WJ, Lai WT, Lin SJ, Yeh SJ, Hwang JJ: 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. Journal of the Chinese Medical Association 2020/07;83(7):587-621
  48. So EC, Liu PY, Wu SN: Effectiveness in the Inhibition of Dapagliflozin and Canagliflozin on M-type K + Current and α-methylglucoside-induced Current in Pituitary Tumor (GH 3) and Pheochromocytoma PC12 Cells. European Journal of Pharmacology 2020/07;879:173141. doi: 10.1016
  49. Dewan P, Solomon SD, Jhund PS, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, DeMets DL, Sabatine MS, Bengtsson O, Sjöstrand M, Langkilde AM, Anand IS, Bělohlávek J, Chopra VK, Dukát A, Kitakaze M, Merkely B, O'Meara E, Schou M, Vinh PN, McMurray JJV; DAPA-HF Investigators and Committees: Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF. European Journal of Heart Failure 2020/07;22(7):1247-1258
  50. Kirichenko TV, Sukhorukov VN, Markin AM, Nikiforov NG, Liu PY, Sobenin IA, Tarasov VV, Orekhov AN, Aliev G: Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis. Frontiers in Pharmacology 2020/04;11:403. doi: 10.3389
  51. Chang CS, Chang YF, Liu PY, Wu SJ, Chiu CJ, Chen CY, Wu CH: Interaction of central obesity and sarcopenia on nutritional status in the community-dwelling older people. Archives of Gerontology and Geriatrics 2020/03;87:104003. doi: 10.1016
  52. Tay WT, Fang YH, Beh ST, Liu YW, Hsu LW, Yen CJ, Liu PY*: Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro. International Journal of Molecular Sciences 2020/03;21(7). pii: E2399.
  53. Fang YH, Wang SPH, Gao ZH, Wu SN, Chang HY, Yang PJ, Liu PY, Liu YW: Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege. International Journal of Molecular Sciences 2020/03;21(7). pii: E2359.
  54. Chang WT, Liu PY, Lee K, Feng YH, Wu SN: Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes. International Journal of Molecular Sciences 2020/02;21(5). pii: E1672.
  55. Chang WT, Gao ZH, Li SW, Liu PY, Lo YC, Wu SN: Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents. International Journal of Molecular Sciences 2020/01;21(2). pii: E396.
  56. Yang CS, Lai MC, Liu PY, Lo YC, Huang CW, Wu SN: Characterization of the Inhibitory Effect of Gastrodigenin and Gastrodin on M-type K+ Currents in Pituitary Cells and Hippocampal Neurons. International Journal of Molecular Sciences 2019/12;21(1) pii: E117
  57. Chang HY, Hsu LW, Lee CH, Lin CC, Huang CW, Chen PW, Yang PK, Hsueh YC, Liu PY*: Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome. Acta Cardiologica Sinica 2019/11;35(6):563-570
  58. Huang TC, Lo LW, Yamada S, Chou YH, Lin WL, Chang SL, Lin YJ, Liu SH, Cheng WH, Tsai TY, Liu PY, Chen SA: Gastroesophageal reflux disease and atrial fibrillation: Insight from autonomic cardiogastric neural interaction. Journal of Cardiovascular Electrophysiology 2019/11;30(11):2262-2270
  59. So EC, Liu PY, Lee CC, Wu SN: High Effectiveness in Actions of Carfilzomib on Delayed-Rectifier K+ Current and on Spontaneous Action Potentials. Frontiers in Pharmacology 2019/10;10:1163
  60. Huang MH, Liu PY, Wu SN: Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents. Frontiers in Chemistry 2019/08;7:566. doi: 10.3389
  61. Ko CY, Liu PY, Chen PW: Successful management of severe acute respiratory distress syndrome caused by sodium polystyrene sulfonate aspiration: A case report. Medicine (Baltimore) 2019/07;98(30):e16574
  62. Hsiao HT, Liu YC, Liu PY, Wu SN: Concerted suppression of Ih and activation of IK(M) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons. Brain Research Bulletin 2019/07;149:11-20
  63. Chen PW, Liu PY*: Postpartum deep vein thrombosis resolved by catheter-directed thrombolysis: A case report. Medicine (Baltimore) 2019/06;98(24):e16052
  64. Chen PW, Hsu LW, Chang HY, Huang TC, Yu JR, Liao HY, Lee CH, Liu PY*: Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus. BioMed Research International 2019/04;2019:8952414
  65. Su CY, Liu PY, Chen PW: Total occlusion of the left main coronary artery presenting as ST-elevation myocardial infarction. BMJ Case Reports 2019/03;12(3) pii: e228658
  66. Huang MS, Lee WH, Tsai HR, Liu YW, Liu PY, Tsai WC: Value of layer-specific strain distribution patterns in hypertrophied myocardium from different etiologies. International Journal of Cardiology 2019/01;281:69-75
  67. Liu YW, Fang YH, Su CT, Hwang SM, Liu PY, Wu SN: The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation. Cell Death Discovery 2019/01;5:59
  68. Lin TK, Yu PT, Lin LY, Liu PY, Li YD, Hsu CT, Cheng YR, Yeh CY, Wong SS, Pai SA, Shee HL, Weng CY: A pilot-study to assess the feasibility and acceptability of an Internet-based cognitive-behavior group therapy using video conference for patients with coronary artery heart disease. PLoS One 2018/11;13(11):e0207931
  69. Wang CM, Chang CS, Chang YF, Wu SJ, Chiu CJ, Hou MT, Chen CY, Liu PY, Wu CH: Inverse Relationship between Metabolic Syndrome and 25-Hydroxyvitamin D Concentration in Elderly People without Vitamin D deficiency. Scientific Reports 2018/11;8(1):17052
  70. Lin TT, Juang JJ, Lee JK, Tsai CT, Chen CH, Yu WC, Cheng HM, Wu YW, Chiu YW, Kuo CT, Chen JJ, Chen ZC, Chang WT, Liu PY, Chen PW, Yen HW, Chen YC, Tseng WK, Chiang FT, Wu CK: Comparison of Home and Ambulatory Blood Pressure Measurements in Association With Preclinical Hypertensive Cardiovascular Damage. Journal of Cardiovascular Nursing 2018/10;doi: 10.1097/JCN.0000000000000515
  71. Li YH, Chao TH, Liu PY, Ueng KC, Yeh HI; Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients. Acta Cardiologica Sinica 2018/09;34(5):371-378
  72. Chen PW, Liu PY*; Pulmonary artery sarcoma mimicking pulmonary embolism. BMJ Case Reports 2018/09;2018. pii: bcr-2018-226999
  73. Chiang CE, Lin SY, Lin TH, Wang TD, Yeh HI, Chen JF, Tsai CT, Hung YJ, Li YH, Liu PY, Chang KC, Wang KL, Chao TH, Shyu KG, Yang WS, Ueng KC, Chu PH, Yin WH, Wu YW, Cheng HM, Shin SJ, Huang CN, Chuang LM, Lin SJ, Yeh SJ, Sheu WH, Lin JL: 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. Journal of the Chinese Medical Association 2018/03;81(3):189-222
  74. Chen IC, Tseng WK, Li YH, Tseng SY, Liu PY, Chao TH: Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9. Oncotarget 2017/11;8(64):108042-108053
  75. Huang MS, Wu CI, Chang FH, Chang HY, Lee PT, Chen JY, Lee WH, Lin CC, Chan SH, Liu PY, Lee CH: The Efficacy and Safety of Using Extension Catheters in Complex Coronary Interventions: A Single Center Experience. Acta Cardiologica Sinica 2017/09;33(5):468-476
  76. Lai HY, Hsu LW, Tsai HH, Lo YC, Yang SH, Liu PY*(Co Corresponding Author), Wang JM: CCAAT/enhancer-binding protein delta promotes intracellular lipid accumulation in M1 macrophages of vascular lesions. Cardiovascular Research 2017/09;113(11):1376-1388
  77. Chiang CE, Wang TD, Lin TH, Yeh HI, Liu PY, Cheng HM, Chao TH, Chen CH, Shyu KG, Ueng KC, Chen CY, Chu PH, Sung SH, Wang KL, Li YH, Wang KY, Chiang FT, Lai WT, Chen JH, Chen WJ, Yeh SJ, Chen MF, Lin SJ, Lin JL: The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension. Acta Cardiologica Sinica 2017/05;33(3):213-225
  78. Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients: 2017 Taiwan lipid guidelines for high risk patients. Journal of the Formosan Medical Association 2017/04;116(4):217-248
  79. Chang WT, Liu YW, Liu PY, Hsu CH, Tsai WC: The association between right ventricular free wall strain and exercise capacity for health check-up subjects. PLoS One 2017/03;12(3):e0173307
  80. Chang WT, Wu CH, Hsu LW, Chen PW, Yu JR, Chang CS, Tsai WC, Liu PY*: Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Scientific Reports 2017/01;7:40996
  81. Chang WT, Chen JS, Tsai MH, Tsai WC, Juang JN, Liu PY*: Interplay of Aging and Hypertension in Cardiac Remodeling: A Mathematical Geometric Model. Plos One 2016/12;11(12):e0168071
  82. Lee PT, Chao TH, Huang YL, Lin SH, Wang WM, Lee WH, Huang CW, Lee CH, Chen JY, Lin CC, Liu PY, Chan SH, Liu YW, Tsai WC, Lin LJ, Tsai LM, Li YH: Analysis of the Clinical Characteristics, Management, and Causes of Death in Patients with ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention from 2005 to 2014. International Heart Journal 2016/09;57(5):541-6
  83. Chang WT, Liu YW, Liu PY, Chen JY, Lee CH, Li YH, Tsai LM, Tsai WC: Association of Decreased Right Ventricular Strain with Worse Survival in Non-Acute Coronary Syndrome Angina. Journal of the American Society of Echocardiography 2016/04;29(4):350-358
  84. Tseng SY, Chao TH, Li YH, Liu PY, Lee CH, Cho CL, Wu HL, Chen JH: Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway. Journal of Vascular Surgery 2016/04;63(4):1051-62
  85. Chen IC, Lee CH, Chao TH, Tseng WK, Lin TH, Chung WJ, Li JK, Huang HL, Liu PY, Chao TK, Chu CY, Lin CC, Hsu PC, Lee WH, Lee PT, Li YH, Tseng SY, Tsai LM, Hwang JJ: Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial. Trials 2016/02;17(1):112


TOP